Session Archive

Buprenorphine Webinars

The following webinars were presented by APA as a partner organization in the Physicians' Clinical Support System for Buprenorphine (PCSS-B). This program ended in May 2013: its successor is the Providers' Clinical Support System for Medication Assisted Treatment (PCSS-MAT). The PCSS-B webinars remain free to the user and provide practical information for physicians who treat opioid use disorders with buprenorphine.

Disclaimer: These webinars are for educational purposes to share the knowledge and opinions of the speakers.  They do not provide medical or legal advice and are intended for physicians who are authorized to prescribe the indicated medication and other interested clinicians.  Clinicians should employ their own clinical judgment and knowledge of the individual patient’s history when diagnosing or prescribing for a patient.

Overview of Addiction

    Addiction: A Chronic Relapsing Disease  


Screening for Substance Use Disorders 
    NIDAMED - Resources to Help Physicians Screen for Drug Use 
    Embedding Addiction Services in General Medicine 
    Initial Interaction and Screening of the Co-Morbid Pain Patient with Problem Opiate Use

Clinical Use of Buprenorphine 
    Integrating Buprenorphine Treatment in Primary Care 
    Buprenorphine Induction and Appropriate Dosing 
    Managing Co-Occurring Addictions 
    Medical Co-morbidities  
    Practical Suggestions for Improving Your Results Using Buprenorphine
    Opioid Maintenance: Terminable or Interminable  
    Newer Formulations of Buprenorphine  
    Minimizing the Risks of Buprenorphine Diversion and Misuse from Office Based Treatment
    The Use of Buprenorphine in the Treatment of Prescription Opioid Dependence 
    Models of Buprenorphine Induction 
    Comparison of Effectiveness of Methadone vs Buprenorphine Maintenance Treatment 
    Implementing Antagonist-Based Relapse Prevention Treatment for Buprenorphine-Treated Individuals
    Focus on Marijuana: Current Risks and Controversies
    Poly-Substance Abuse in Office-Based Buprenorphine Treatment
    Integrating Buprenorphine/Naloxone Into An Opioid Treatment Program
    Pain Management in Patients on Buprenorphine Maintenance
    Management of Buprenorphine Side Effects

Special Populations 
    Inducting and Stabilizing Opioid-Dependent Pregnant Women on Methadone or Buprenorphine: Current Research 
    and Future Treatment Implications
    Buprenorphine Treatment of Opioid Dependence in Adolescents and Young Adults 
    Buprenorphine Treatment in Rural Communities 
    Buprenorphine Treatment During Pregnancy 

Psychosocial interventions 
Lessons Learned from Addiction Psychiatry: The Motivational Interviewing Approach to Change 
    Network Therapy: Using the Patient’s Family and Peer Support for Effective Office Practice 

Office Management and Reimbursement 
    What Waivered Physicians Need to Understand About DEA Requirements 
    The Business Case for Opioid-Dependence and Alcohol-Dependence Medications
    Enhancing Access to Prescription Drug Monitoring Programs Through Health Information Technology 
    Confidentiality of Substance Abuse Treatment Records
    Opioid Dependence and the Future of Treatment: Buprenorphine in the VA